Hanitrarimalala Veroniaina

Statistics

Publications

Citations

241

H-Index

Active since

2019

Affiliations

China Pharmaceutical University(Current)

Monash University

Australian Regenerative Medicine Institute

Hanitrarimalala Veroniaina is an author at China Pharmaceutical University specializing in drug delivery, nanomaterials for drug delivery, and pharmacy.

ORCID

Publications per year

2019–2021

Publications

ROS‐Mediated Apoptosis and Anticancer Effect Achieved by Artesunate and Auxiliary Fe(II) Released from Ferriferous Oxide‐Containing Recombinant Apoferritin

Peng Ji, Haiqin Huang, Shirui Yuan et al. · Advanced Healthcare Materials · 2019 · 68 citations

Life Sciences, Oncology, Pharmacology +17

Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use

Hanitrarimalala Veroniaina, Zhenghong Wu, Xiaole Qi · Journal of Advanced Research · 2021 · 44 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose

Wen Yang, Hanitrarimalala Veroniaina, Xiaole Qi et al. · Advanced Therapeutics · 2019 · 43 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Poly(<i>N</i>-isopropylacrylamide) derived nanogels demonstrated thermosensitive self-assembly and GSH-triggered drug release for efficient tumor Therapy

Jiaojiao Chen, Ming Wu, Hanitrarimalala Veroniaina et al. · Polymer Chemistry · 2019 · 31 citations

Pharmacy, Oncology, Pharmaceutics +17

Ca<sup>2+</sup> participating self-assembly of an apoferritin nanostructure for nucleic acid drug delivery

Haiqin Huang, Kang Sha, Hanitrarimalala Veroniaina et al. · Nanoscale · 2020 · 23 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

1–5 of 7